SOURCE: Kadmon Corporation

Kadmon Corporation

September 03, 2015 09:30 ET

Kadmon Corporation to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

NEW YORK, NY--(Marketwired - Sep 3, 2015) - Kadmon Corporation, LLC today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer of Kadmon, will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015 at 12:05 p.m. ET in New York. Dr. Waksal will provide an overview of Kadmon and its clinical and commercial programs.

A live audio webcast of the presentation will be accessible at wsw.com/webcast/rrshq25/kadm. The replay will be available for 90 days following the presentation. 

About Kadmon Corporation
Kadmon Corporation, LLC is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in oncology, autoimmune and fibrotic diseases, metabolic disease and certain monogenic diseases. For more information, visit www.kadmon.com.

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Contact Information

  • Contact Information
    Ellen Tremaine
    Investor Relations
    646.490.2989
    Email Contact